These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32385660)

  • 41. Association of variability in hemoglobin A1c with cardiovascular diseases and mortality in Chinese patients with type 2 diabetes mellitus - A retrospective population-based cohort study.
    Wan EY; Fung CS; Fong DY; Lam CL
    J Diabetes Complications; 2016; 30(7):1240-7. PubMed ID: 27318537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Age-specific associations of glycated haemoglobin variability with cardiovascular disease and mortality in patients with type 2 diabetes mellitus: A 10- year cohort study.
    Wan EYF; Yu EYT; Chin WY; Ng FTY; Chia SMC; Wong ICK; Chan EWY; Lam CLK
    Diabetes Obes Metab; 2020 Aug; 22(8):1316-1327. PubMed ID: 32196917
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High serum osteopontin levels are associated with prevalent fractures and worse lipid profile in post-menopausal women with type 2 diabetes.
    Filardi T; Carnevale V; Massoud R; Russo C; Nieddu L; Tavaglione F; Turinese I; Lenzi A; Romagnoli E; Morano S
    J Endocrinol Invest; 2019 Mar; 42(3):295-301. PubMed ID: 29916137
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HbA1c variability as an independent predictor of diabetes retinopathy in patients with type 2 diabetes.
    Hu J; Hsu H; Yuan X; Lou K; Hsue C; Miller JD; Lu J; Lee Y; Lou Q
    J Endocrinol Invest; 2021 Jun; 44(6):1229-1236. PubMed ID: 32897535
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Visit-to-Visit Variations in Fasting Plasma Glucose and HbA
    Li TC; Yang CP; Tseng ST; Li CI; Liu CS; Lin WY; Hwang KL; Yang SY; Chiang JH; Lin CC
    Diabetes Care; 2017 Sep; 40(9):1210-1217. PubMed ID: 28705834
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic importance of baseline and serial glycated hemoglobin levels in high-risk patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CR; Leite NC; Ferreira MT; Salles GF
    Acta Diabetol; 2015 Feb; 52(1):21-9. PubMed ID: 24816865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Haemoglobin A1c variability is a strong, independent predictor of all-cause mortality in patients with type 2 diabetes.
    Orsi E; Solini A; Bonora E; Fondelli C; Trevisan R; Vedovato M; Cavalot F; Gruden G; Morano S; Nicolucci A; Penno G; Pugliese G;
    Diabetes Obes Metab; 2018 Aug; 20(8):1885-1893. PubMed ID: 29582548
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Correlation between glycemic variability and glycosylated hemoglobin level during follow-up in elderly male patients with type 2 diabetes in Beijing].
    Fang FS; Wang N; Liu XY; Yan ST; Li CL; Tian H
    Zhonghua Nei Ke Za Zhi; 2022 Nov; 61(11):1234-1238. PubMed ID: 36323565
    [No Abstract]   [Full Text] [Related]  

  • 49. Predictive Value of Fasting Glucose, Postload Glucose, and Hemoglobin A
    Lu J; He J; Li M; Tang X; Hu R; Shi L; Su Q; Peng K; Xu M; Xu Y; Chen Y; Yu X; Yan L; Wang T; Zhao Z; Qin G; Wan Q; Chen G; Dai M; Zhang D; Gao Z; Wang G; Shen F; Luo Z; Qin Y; Chen L; Huo Y; Li Q; Ye Z; Zhang Y; Du R; Cheng D; Liu C; Wang Y; Wu S; Yang T; Deng H; Li D; Lai S; Bloomgarden ZT; Chen L; Zhao J; Mu Y; Ning G; Wang W; Bi Y;
    Diabetes Care; 2019 Aug; 42(8):1539-1548. PubMed ID: 31152120
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-Term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD Study.
    Scott ES; Januszewski AS; O'Connell R; Fulcher G; Scott R; Kesaniemi A; Wu L; Colagiuri S; Keech A; Jenkins AJ
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32766757
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: The Fremantle Diabetes Study Phase I.
    Davis WA; Hamilton EJ; Bruce DG; Davis TME
    Diabetes Care; 2019 Jan; 42(1):102-109. PubMed ID: 30455327
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incident type 2 diabetes and hip fracture risk: a population-based matched cohort study.
    Martinez-Laguna D; Tebe C; Javaid MK; Nogues X; Arden NK; Cooper C; Diez-Perez A; Prieto-Alhambra D
    Osteoporos Int; 2015 Feb; 26(2):827-33. PubMed ID: 25488807
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes.
    Yang CY; Su PF; Hung JY; Ou HT; Kuo S
    Cardiovasc Diabetol; 2020 Jul; 19(1):105. PubMed ID: 32631323
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of Fasting Glucose Levels on Achieving Glycemic Target in Individuals with Type 2 Diabetes: a Post Hoc Analysis.
    Ma J; Lei M; Li Y; Zhang X; Cui N; Yang W
    Adv Ther; 2020 Sep; 37(9):3816-3826. PubMed ID: 32671687
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential risk of fracture attributable to type 2 diabetes mellitus according to skeletal site.
    Schousboe JT; Morin SN; Kline GA; Lix LM; Leslie WD
    Bone; 2022 Jan; 154():116220. PubMed ID: 34571204
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women.
    Pradhan AD; Rifai N; Buring JE; Ridker PM
    Am J Med; 2007 Aug; 120(8):720-7. PubMed ID: 17679132
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Visit-to-visit variability of glycemia and vascular complications: the Hoorn Diabetes Care System cohort.
    Slieker RC; van der Heijden AAWH; Nijpels G; Elders PJM; 't Hart LM; Beulens JWJ
    Cardiovasc Diabetol; 2019 Dec; 18(1):170. PubMed ID: 31830993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of generic exenatide injection in Chinese patients with type 2 diabetes: a multicenter, randomized, controlled, non-inferiority trial.
    Yang J; Xiao W; Guo L; Li Q; Zhong L; Yang J; Yang J; Gao Y; Tian Q; Hong T
    Acta Diabetol; 2020 Aug; 57(8):991-1000. PubMed ID: 32206903
    [TBL] [Abstract][Full Text] [Related]  

  • 59. THE ADDED AND INTERPRETATIVE VALUE OF CGM-DERIVED PARAMETERS IN TYPE 1 DIABETES DEPENDS ON THE LEVEL OF GLYCEMIC CONTROL.
    Helleputte S; De Backer T; Calders P; Pauwels B; Shadid S; Lapauw B
    Endocr Pract; 2021 Jan; 27(1):44-50. PubMed ID: 33475500
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Duration of Diabetes, Glycemic Control, and Risk of Heart Failure Among Adults With Diabetes: A Cohort Study.
    Yang HH; Li FR; Chen ZK; Zhou MG; Xie LF; Jin YY; Li ZH; Chen GC
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1166-1172. PubMed ID: 36383477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.